Infectious Disease Alert – December 1, 2006
December 1, 2006
View Issues
-
HIV Integrase Inhibitors Show Potent Activity in Clinical Trials
Since 1995, the outlook for patients with hiv infection has improved significantly with the advent of triple-drug-potent antiretroviral (ARV) therapy regimens. -
Rifaximin (Xifaxan®)
Travelers' diarrhea is the most common clincal ailment affecting tourism among travelers who move from industrialized to developing countries. -
Antibiotics in the ICU: Cycling, Mixing, or Personalization?
Sandiumenge and colleagues evaluated the effects of 3 strategies of antibiotic prescribing in a 14-bed ICU. -
Updates By Carol A. Kemper, MD, FACP
An effective vaginal (or anal/ penile) microbicide could substantially diminish the risk of transmission of HIV, especially in the developing world where condom use has not gained uniform acceptance. -
Pharmacology Watch: Sweeping Changes Needed for US Drug Safety System
Antiaging Supplements Proven Ineffective; The Three Most Common Culprits of ADE; New Guidelines for Lyme Disease Prevention; FDA Actions -
Clinical Briefs in Primary Care supplement